Thoughts On Going Public During The Pandemic And The "Muted" Celebration
Source: Life Science Leader
In this executive virtual roundtable (EVR) segment, Marcio Souza, CEO of Praxis Precision Medicines, a clinical stage biopharma, kicks off the conversation sharing his thought on the “muted” celebration from IPOing during the pandemic. Providing additional perspectives are Tom Frohlich (CBO, Chinook Therapeutics), and David Perry (cofounder and chairman of Better Therapeutics).
This website uses cookies to ensure you get the best experience on our website. Learn more